AI healthcare
-
VSee Health Stock Surges After FedRAMP High Authorization: What Investors Need to Know
VSee Health’s stock soared after receiving FedRAMP High authorization, paving the way for expanded government partnerships. This major security certification brings new opportunities—and risks—for investors navigating a volatile healthcare tech sector.
-
Tempus AI Responds to Short Seller Allegations
Tempus AI defends itself after a critical short report by Spruce Point Capital, addressing allegations of aggressive accounting and weakened partnerships.
-
NVIDIA’s $10 Trillion Vision: Revolutionizing Healthcare with AI and Accelerated Computing
NVIDIA’s ambitious initiative to reshape the $10 trillion healthcare and life sciences industry has captured global attention. Announced at the J.P. Morgan Healthcare Conference, partnerships with IQVIA, Illumina, Mayo Clinic, and Arc Institute signal a bold step toward integrating artificial…